The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Exanthema

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Exanthema.
Andrzej Jakubowiak
Connection Strength
0.029
Exanthema
  1. Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients. Blood. 2014 Aug 14; 124(7):1038-46.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.